cigna glp 1 2025 requirements Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss US is only country debating

I need to drop 15-20 pounds. Mar 26, 2026 Individual results may vary

1 Introduction Diabetes mellitus (DM) is a metabolic disease characterized by hyperglycemia (elevated blood glucose), which is caused by a lack of insulin or failure of insulin, resulting in cells being unable to absorb glucose, thus increasing blood glucose levels

Medical professionals have identified five distinct forms of pancreatitis in Ozempic users, each carrying different prognoses: Acute Pancreatitis : The most common form, affecting 80% of cases, characterized by sudden inflammation that typically resolves but can trigger lasting motility disorders with mortality rates below 2% in mild cases Necrotizing Pancreatitis : Occurring in 20-30% of severe cases, involving tissue death within the pancreas that increases the risk of permanent gastroparesis, with mortality rates ranging from 15-30% Hemorrhagic Pancreatitis : A severe variant specifically mentioned in FDAs 2025 updated warnings, involving bleeding within the pancreas and carrying mortality rates exceeding 30% Chronic Pancreatitis : Progressive inflammation leading to permanent scarring and dysfunction, strongly associated with persistent gastroparesis development The FDAs January 2025 update to the ozempic warning label specifically added warnings about fatal and non-fatal hemorrhagic or necrotizing pancreatitis and other serious adverse events including anterior ischemic optic neuropathy, acknowledging the serious nature of these complications

Keep a food journal for a week to track what youre eating, and prioritize nutrient-rich choices like lean protein (aim for about 30g per meal) and high-fiber vegetables

Research has found that GLP-1 agonists like semaglutide can even reduce the incidence of major cardiac events, like strokes and heart attacks, by 20%